PMDA approves NextPharma Braine-l’Alleud facility
NextPharma claims that its Belgian site, Braine-l’Alleud, has extensive know how in aseptic production and packaging including the manufacture of cytotoxic products (lyophilization and solutions) gained over more
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.